Surprise! Mylan's Copaxone Generic Sets Teva Up For A Struggle

 
• By Jessica Merrill

FDA cleared Mylan's generic version of Copaxone 40mg even after management warned investors not to expect action until 2018. Mylan said it will launch "imminently, but Teva said a launch ahead of the pending appeals case would be "at risk."

FDA approved background, 3D rendering, blue street sign

More from New Products

More from Scrip